CLINICAL CASE OF A PATIENT WITH EXTREME HYPERTROPHIC CARDIOMYOPATHY AND RECURRENT IDIOPATHIC TRANSUDATIVE PERICARDIAL EFFUSION

HighlightsWe report a case of a patient with extreme hypertrophic cardiomyopathy and complex cardiac pathology undergoing heart transplantation. The article will be useful for cardiologists, therapists and cardiovascular surgeons. AbstractWe present a case of a patient with extreme hypertrophic cardiomyopathy, Wolff–Parkinson–White syndrome and nonspecific chronic exudative pericardial effusion with recurrent idiopathic transudative pericardial effusion. This case involves several approaches to treatment – medication and surgery for treating a patient with combined cardiomyopathy and pericardial effusion, which served as a “bridge” for a later change inro radical treatment - orthotopic heart transplantation.

[1]  V. Kittipibul,et al.  Idiopathic pericardial effusion in patients with hypertrophic cardiomyopathy , 2021, The International Journal of Cardiovascular Imaging.

[2]  J. Jefferies,et al.  Clinical Insights Into Heritable Cardiomyopathies , 2021, Frontiers in Genetics.

[3]  B. Maron,et al.  Global Burden of Hypertrophic Cardiomyopathy. , 2018, JACC. Heart failure.

[4]  S. Kachboura,et al.  Risk stratification in hypertrophic cardiomyopathy , 2018, Herz.

[5]  T. Ryan,et al.  The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  B. Iung,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[7]  A. Anastasakis,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[8]  Y. Adler,et al.  Management of pericardial effusion. , 2013, European heart journal.

[9]  T. Sejersen,et al.  Deletion in TNNI3 gene is associated with restrictive cardiomyopathy. , 2009, International journal of cardiology.

[10]  C. Appleton,et al.  Echocardiographic determination of mean pulmonary artery pressure. , 2003, The American journal of cardiology.